ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Biora Therapeutics Inc

Biora Therapeutics Inc (PROG)

0.8845
0.00
(0.00%)
마감 09 2월 6:00AM
0.00
0.00
(0.00%)
시간외 거래: -

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
0.8845
매수가
0.8845
매도가
0.89
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
market_cap
전일 종가
0.8845
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
23,704,000
배당수익률
-
주가수익률
-0.17
주당순이익(EPS)
-5.24
매출
4k
순이익
-124.12M

Biora Therapeutics Inc 정보

Biora Therapeutics Inc, formerly Progenity Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the ... Biora Therapeutics Inc, formerly Progenity Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States. It generates revenue from providing molecular laboratory tests to customers. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Dover, Delaware, USA
설립됨
-

PROG 최신 뉴스

Progenity Announces Successful Transfer of Liquid Biopsy Technologies

SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG) today announced it has completed the divesture of a collection of novel, discovery-stage biochemical and bioinformatics...

Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.

SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG) today announced that it will report first quarter ended March 31, 2022 financial results on Tuesday, May 10, 2022 after...

Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms

SAN DIEGO, April 25, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond...

Progenity to Become Biora Therapeutics as it Completes Transformation

SAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond...

Progenity Announces Two Poster Presentations at Controlled Release Society 2022

SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond...

Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Accelerated Company Transformation Toward Oral Delivery of Biotherapeutics and Targeted Therapeutics Programs Progressed Company’s Targeted Therapeutics Clinical Programs with Initiation of...

Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond...

Progenity Progresses its Drug Delivery System Clinical Device Performance Studies

Clinical Device Performance Study in Healthy Volunteers Demonstrated Accurate Localization and Delivery A Clinical Device Performance Study in Patients with Ulcerative Colitis is Now Recruiting...

Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...

Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22

SAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PROG - Frequently Asked Questions (FAQ)

What is the current Biora Therapeutics share price?
The current share price of Biora Therapeutics is US$ 0.8845
How many Biora Therapeutics shares are in issue?
Biora Therapeutics has 23,704,000 shares in issue
What is the market cap of Biora Therapeutics?
The market capitalisation of Biora Therapeutics is USD 20.97M
What is the 1 year trading range for Biora Therapeutics share price?
Biora Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Biora Therapeutics?
The price to earnings ratio of Biora Therapeutics is -0.17
What is the cash to sales ratio of Biora Therapeutics?
The cash to sales ratio of Biora Therapeutics is 4.4k
What is the reporting currency for Biora Therapeutics?
Biora Therapeutics reports financial results in USD
What is the latest annual turnover for Biora Therapeutics?
The latest annual turnover of Biora Therapeutics is USD 4k
What is the latest annual profit for Biora Therapeutics?
The latest annual profit of Biora Therapeutics is USD -124.12M
What is the registered address of Biora Therapeutics?
The registered address for Biora Therapeutics is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Biora Therapeutics website address?
The website address for Biora Therapeutics is www.bioratherapeutics.com
Which industry sector does Biora Therapeutics operate in?
Biora Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
CDTConduit Pharmaceuticals Inc
US$ 2.831
(82.65%)
144.17M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
TOIIWOncology Institute Inc
US$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
US$ 1.19
(54.55%)
84.73M
FTELFitell Corporation
US$ 2.70
(-57.01%)
2.3M
SGBXSafe and Green Holdings Corporation
US$ 0.6401
(-44.82%)
5.65M
NKLANikola Corporation
US$ 0.4432
(-41.10%)
52.44M
PLRXPliant Therapeutics Inc
US$ 7.785
(-34.85%)
6.44M
LIPOLipella Pharmaceuticals Inc
US$ 3.08
(-33.76%)
2.2M
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
RIMEAlgorhythm Holdings Inc
US$ 0.0169
(-20.66%)
274.2M
NVDANVIDIA Corporation
US$ 129.84
(0.90%)
228.2M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0537
(14.74%)
212.29M

PROG Discussion

게시물 보기
AstronautApe_888 AstronautApe_888 2 년 전
Is Biora Therapeutics (PROG) Stock About to Go Big?
https://franknez.com/is-biora-therapeutics-prog-stock-about-to-go-big/
👍️0
pinkslipjunkie pinkslipjunkie 3 년 전
What happened here...it looks like trading has halted since May 6th 2022
👍️0
Hobbydigger-53 Hobbydigger-53 3 년 전
Hi, what to expect on the 28th ? Anyone with some outlook 3month or 12 month ? What about sufficient cash ? I´m even these levels but didnt sell all shares last high. I´m somewhat without any gut feeling this time...
👍️0
nathanial nathanial 3 년 전
You got that right!
👍️0
Deano361 Deano361 3 년 전
The pumpers got ahead of it last time . Or mms pumping for selling their new shelf shares ? Possibly
👍️0
Limey42 Limey42 3 년 전
About bloody time!!!!
👍️0
Deano361 Deano361 3 년 전
Gametime!!

https://www.sciencedirect.com/science/article/abs/pii/S0731708522001509

👍️0
Deano361 Deano361 3 년 전
This turned into something different than expected. Athyrium is crooked . Sold shelf when shorts were dead in water otherwise . Still holding !
👍️0
MASTERULTRA MASTERULTRA 3 년 전
$1.23 is on the ask.
👍️0
MASTERULTRA MASTERULTRA 3 년 전
Please god,let us close $1.30
👍️0
MASTERULTRA MASTERULTRA 3 년 전
Holyshit, its a miracle thank you jesus!!!
👍️0
da_stock_analyst da_stock_analyst 3 년 전
#PROG ?? Nice uptrend! Are you in or waiting for dips? Chart analysis and price target !
👍️0
Deano361 Deano361 3 년 전
Yes
👍️0
da_stock_analyst da_stock_analyst 3 년 전
#PROG ?? is it reversing? Good to re-enter for a swing trade? My price target and thoughts!
👍️0
plumber652 plumber652 3 년 전
Options chain getting nice and full for next week. Over 2 bucks and this should move nicely to the upside.
👍️0
tooltimetim tooltimetim 3 년 전
Much dilution, debt reduction off of the backs of apes, good for PROG possibly, bad for a squeeze
👍️0
dmerc dmerc 3 년 전
added premarket. Jan' effect needs to kick in!
👍️0
Deano361 Deano361 3 년 전
Every dog gets it's day and we will get ours!!!
👍️0
Torez Torez 3 년 전
Phew, I almost missed the boat lol
👍️0
Stockman1010101 Stockman1010101 3 년 전
PROG IS GOING UP TODAY. BABY.
GLTA PROG APES
👍️0
ErvinFamly74 ErvinFamly74 3 년 전
Still here. Just watching. Waiting to strike.
👍️0
Torez Torez 3 년 전
What happened to all the monkeys here? I though this by now will be $30 lol
👍️0
Torez Torez 3 년 전
Another great day here lol
👍️0
masterofdisaster masterofdisaster 3 년 전
Much respect my friend
👍️0
Torez Torez 3 년 전
Seem good new yet pos 8% down - pumpers please explain
👍️0
foti1kenobi foti1kenobi 3 년 전
In Gary Genslers words help keep the market free from "bad actors"
If you see any post that may be seen as an attempt at stock manipulation feel free to contact the SEC whistleblower program. Most times these "bad actors" have a position or are working with someone who has a short position in a company or would otherwise benefit from making up inaccurate posts.

https://www.sec.gov/whistleblower
You'd be surprised how active the SEC has become on cleaning things up.
Reach out if you feel you see any Nefarious activities in PROG or any other company you follow.
They will take it from their

Here is a recent example how social media can be used illegally:

SEC Wins Jury Trial: Hedge Fund Adviser Found Liable for Securities Fraud
FOR IMMEDIATE RELEASE
2021-224
Washington D.C., Nov. 5, 2021 —
Jurors in Boston federal court today returned a verdict in the Securities Exchange Commission’s favor against a hedge fund adviser and his investment advisory firm.

Gregory Lemelson and Massachusetts-based Lemelson Capital Management LLC were charged with fraud in September 2018 for reaping more than $1.3 million in illegal profits by making false statements to drive down the price of San Diego-based Ligand Pharmaceuticals Inc. The SEC’s evidence at trial showed that after establishing a short position in Ligand through his hedge fund, Lemelson made a series of false statements to shake investor confidence in Ligand and lower its stock price, increasing the value of his fund’s position. The false statements included assertions that Ligand’s investor relations firm had agreed that Ligand’s most profitable drug was on the brink of obsolescence and that Ligand had entered into a sham transaction with an unaudited shell company in order to pad its balance sheet. The evidence also showed that Lemelson had boasted about bringing down Ligand’s stock price through his “multi-month battle” against the company.

The jury found Lemelson and Lemelson Capital Management liable for fraudulent misrepresentations. The court will determine remedies at a later date.

“Investment professionals play a crucial role in our markets and when they break the law they undermine investors’ trust,” said Gurbir S. Grewal, Director of the SEC’s Division of Enforcement. “We’ll continue to use all of the tools in our toolkit to hold wrongdoers accountable, including litigating whenever necessary. This verdict underscores that commitment as well as our staff’s ability, tenacity, and experience to win those trials.”
👍️0
Torez Torez 3 년 전
Oh went red again??? Shocking
👍️0
foti1kenobi foti1kenobi 3 년 전
You ever have to give your daughter her weekly shot and watch her cry Torez?
This company is preventing that from happening.
But congratulations on all your success.
👍️0
Deano361 Deano361 3 년 전
I have no doubt
👍️0
Stockman1010101 Stockman1010101 3 년 전
it will soon.
👍️0
ttottip ttottip 3 년 전
Yes, yesterday many people panicked and sold their shares.
👍️0
Deano361 Deano361 3 년 전
I'd say one difference. this has not gone to moon as the other two you mentioned.
👍️0
Deano361 Deano361 3 년 전
pretty much. We will go higher based on what is up their sleeve in 2022. Only real catalysts will take us there.
👍️0
Torez Torez 3 년 전
See here is your problem - the apes part, this thing was already ape-ed, just like AMC Game Stop and few others. Some believe they will run hard again - but no way, apes moved to anothers
👍️0
Stockman1010101 Stockman1010101 3 년 전
This is going much higher. Load up or miss this train.
GLTA PROG APES.
👍️0
Torez Torez 3 년 전
This was just typical Pump and Dump, now its clearly relentless dumping
👍️0
masterofdisaster masterofdisaster 3 년 전
Bottom line is the offering and the private placement got the market makers off the hook and retail has completely lost interest.
👍️0
ttottip ttottip 3 년 전
Gradually.
👍️0
foti1kenobi foti1kenobi 3 년 전
I do believe today is the last day for tax harvesting. Good luck patting yourself on the back everyday a pharmaceutical company that is attempting to save lives stock price gets walked down.
This will rip faces off next year
👍️0
foti1kenobi foti1kenobi 3 년 전
A company with a patent on taking injectable drugs ingestible has groundbreaking IP. Think about any company that changed the game. Now think about getting in those under $2
Exactly
Now think of hoping this company fails while aging and most likely one day needing this technology for yourself, your spouse, your kids. Think of the type of person that takes
👍️0
Torez Torez 3 년 전
Yeah from $5 down to 1.8 in only few weeks, what a pos
👍️0
ttottip ttottip 3 년 전
Just panic selling. The price will rise gradually. Red days don't last forever.
👍️0
Torez Torez 3 년 전
$1 will come fast now lol . Torez 1 - Pumpers 0
👍️0
Torez Torez 3 년 전
Lol yup since $3
👍️0
ttottip ttottip 3 년 전
Good morning all ! Waiting for the short squeeze.
👍️0
Torez Torez 3 년 전
Welcome to 1s
👍️0
Torez Torez 3 년 전
No you said - tomorrow very green
👍️0
Stockman1010101 Stockman1010101 3 년 전
prog on sale now. buy, buy, buy.
👍️0
Stockman1010101 Stockman1010101 3 년 전
it could. I do not look at it hour by hour. I look at it week by week. Still gonna be very green in a week or so. Load up now while it's at the support level.
GLTA PROG APES.
👍️0
Torez Torez 3 년 전
Dont get too cocky buddy - only 3%, and this could end up red
👍️0